Coya Therapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $3,959 | $3,564 | $163 | $257 |
Gross Profit | 9,160 | 3,557 | 156 | -4,956 |
EBITDA | -4,371 | -2,108 | -6,088 | -7,670 |
EBIT | -4,377 | -2,115 | -6,094 | -7,676 |
Net Income | -5,708 | -2,115 | -6,094 | -7,306 |
Net Change In Cash | 3,959 | 3,564 | 163 | 257 |
Free Cash Flow | -11,419,423 | -1,130 | -5,773 | -2,828 |
Cash | 46,822 | 28,129 | 29,757 | 35,530 |
Basic Shares | 16,730 | 16,732 | 16,724 | 16,721 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $7,945 | $3,554 | $6,002 | $0 |
Gross Profit | 7,918 | -8,311 | 500 | -4,412 |
EBITDA | -20,238 | -17,197 | -7,332 | -9,259 |
EBIT | -20,265 | -17,224 | -7,360 | -9,286 |
Net Income | -21,226 | -14,880 | -7,987 | -12,244 |
Net Change In Cash | 7,945 | 3,554 | 6,002 | 0 |
Free Cash Flow | -10,739 | -10,288 | -11,188 | -7,239 |
Cash | 46,822 | 38,339 | 32,626 | 5,933 |
Basic Shares | 16,730 | 15,239 | 10,164 | 9,947 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.27 |
2025-09-30 | -$0.13 |
2025-06-30 | -$0.36 |
